prevent
therapeut
efficaci
halofuginonelact
hfl
cryptosporidium
parvum
evalu
studi
conduct
novemb
march
dairi
farm
central
bohemia
czech
republ
use
spontan
infect
calv
hfl
mgkgday
administ
oral
day
calv
respect
treat
group
drug
significantli
almost
manner
decreas
intens
diarrhoea
p
faecal
oocyst
count
p
compar
correspond
placebo
group
differ
treat
group
time
onset
symptom
infect
time
clinic
pattern
cryptosporidiosi
anim
treat
day
age
similar
seen
group
receiv
placebo
contrast
infect
prevent
treat
group
peak
day
later
intens
result
studi
confirm
anticryptosporidi
activ
hfl
calv
show
outcom
infect
follow
prevent
treatment
compar
observ
calv
treat
onset
symptom
cryptosporidium
parvum
recognis
one
major
caus
enter
diarrhoea
neonat
calv
treatment
difficult
fayer
et
al
de
graaf
et
al
date
halofuginonelact
hfl
seem
promis
drug
bovin
cryptosporidiosi
villacorta
et
al
naciri
et
al
peeter
et
al
lefay
et
al
joachim
et
al
jarvi
et
al
although
hfl
commonli
recommend
prevent
therapi
efficaci
compar
experiment
recommend
ration
use
suffici
document
aim
studi
compar
effect
recommend
day
administr
mgkg
hfl
prevent
treatment
cryptosporidiosi
spontan
infect
calv
centralis
randomis
doubleblind
placebocontrol
studi
newborn
holstein
calv
conduct
novemb
march
dairi
farm
locat
central
bohemia
dam
high
preval
cryptosporidiosi
newborn
anim
studi
began
found
anim
month
age
herd
posit
coronaviru
rotaviru
found
calv
mainli
age
week
twentytwo
percent
anim
mainli
week
age
posit
escherichia
coli
presenc
campylobact
jejuni
clostridium
perfringen
document
anim
respect
preval
c
parvum
infect
calv
day
age
neither
salmonella
bvd
viru
demonstr
farm
studi
period
viabl
newborn
anim
alloc
accord
order
birth
four
group
anim
receiv
hfl
day
age
b
anim
receiv
placebo
age
c
anim
receiv
hfl
day
age
anim
receiv
placebo
age
day
final
number
anim
group
respect
hfl
dose
mgkg
administ
oral
day
h
morn
feed
aqueou
solut
halocur
intervet
solut
composit
omit
activ
ingredi
use
placebo
throughout
studi
group
separ
calv
randomli
alloc
pen
place
concret
floor
farm
shed
time
receiv
standard
husbandri
veterinari
care
calv
observ
daili
consist
faec
score
four
point
scale
faecal
sampl
parasitolog
examin
collect
rectal
everi
morn
examin
describ
casemor
et
al
oocyst
count
also
express
four
point
scale
faecal
score
obtain
daili
calv
age
day
order
characteris
overal
pattern
infect
averag
score
mean
faecal
score
calcul
anim
similarli
daili
intens
diarrhoea
mean
intens
diarrhoea
period
calcul
data
statist
compar
use
oneway
anova
hfl
significantli
decreas
oocyst
excret
well
intens
diarrhoea
first
day
life
administ
prevent
therapeut
tabl
fig
peak
oocyst
shed
untreat
group
occur
day
oocyst
shed
pattern
time
group
treat
hfl
day
age
placebo
group
contrast
group
receiv
hfl
day
age
oocyst
count
minim
day
concentr
faecal
oocyst
increas
reach
peak
day
increas
oocyst
output
coincid
higher
preval
diarrhoea
fig
group
receiv
placebo
one
anim
day
placebo
group
posit
cryptosporidia
total
five
neg
anim
seen
hfl
treat
group
conclud
hfl
significantli
inhibit
c
parvum
infect
suppress
symptom
surprisingli
final
effect
appear
independ
whether
drug
administ
prevent
therapeut
differ
treat
group
delay
oocyst
output
occurr
diarrhoea
infect
prevent
treat
group
peak
day
later
benefit
use
prevent
treatment
hfl
therefor
question
hand
postnat
calv
suscept
acidbas
balanc
disturb
dehydr
associ
sever
diarrhoea
sinc
risk
decreas
age
virtala
et
al
tabl
mean
faecal
score
mean
intens
diarrhoea
day
age
calv
treat
halofuginonelact
hfl
day
day
age
hfl
valu
unlik
superscript
differ
significantli
p
may
argu
prevent
use
hfl
delay
infect
age
anim
resili
minim
differ
prevent
therapeut
effect
drug
allow
practition
choos
treatment
option
accord
circumst
